The global Animal Health Active Pharmaceutical Ingredients market was valued at US$ 61290 million in 2023 and is anticipated to reach US$ 91040 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 30%.
This report aims to provide a comprehensive presentation of the global market for Animal Health Active Pharmaceutical Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Health Active Pharmaceutical Ingredients.
Report Scope
The Animal Health Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Health Active Pharmaceutical Ingredients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Health Active Pharmaceutical Ingredients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Glenmark Pharmaceutical
Zoetis
Eli Lilly
Sanofi Winthrop Industrie
Indukern
P&R SpA (Olon SpA)
Lonza Group
Huvepharma
Sequent Scientific
NGL Fine Chem
Segment by Type
Antiparasitics
Anti-infectives
NSAIDs & Anesthetics
Others
Segment by Application
Pharmacy
Pet Hospital
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Health Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Health Active Pharmaceutical Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Overview
1.1 Product Overview and Scope of Animal Health Active Pharmaceutical Ingredients
1.2 Animal Health Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Antiparasitics
1.2.3 Anti-infectives
1.2.4 NSAIDs & Anesthetics
1.2.5 Others
1.3 Animal Health Active Pharmaceutical Ingredients Segment by Application
1.3.1 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Pet Hospital
1.3.4 Other
1.4 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Animal Health Active Pharmaceutical Ingredients Revenue 2019-2030
1.4.2 Global Animal Health Active Pharmaceutical Ingredients Sales 2019-2030
1.4.3 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Competition by Manufacturers
2.1 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Animal Health Active Pharmaceutical Ingredients Average Price by Manufacturers (2019-2024)
2.4 Global Animal Health Active Pharmaceutical Ingredients Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal Health Active Pharmaceutical Ingredients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Health Active Pharmaceutical Ingredients, Product Type & Application
2.7 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Competitive Situation and Trends
2.7.1 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Health Active Pharmaceutical Ingredients Players 麻豆原创 Share by Revenue
2.7.3 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Health Active Pharmaceutical Ingredients Retrospective 麻豆原创 Scenario by Region
3.1 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Animal Health Active Pharmaceutical Ingredients Global Animal Health Active Pharmaceutical Ingredients Sales by Region: 2019-2030
3.2.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Region: 2019-2024
3.2.2 Global Animal Health Active Pharmaceutical Ingredients Sales by Region: 2025-2030
3.3 Global Animal Health Active Pharmaceutical Ingredients Global Animal Health Active Pharmaceutical Ingredients Revenue by Region: 2019-2030
3.3.1 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region: 2019-2024
3.3.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region: 2025-2030
3.4 North America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.4.1 North America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Animal Health Active Pharmaceutical Ingredients Sales by Country (2019-2030)
3.4.3 North America Animal Health Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Health Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.5.1 Europe Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Animal Health Active Pharmaceutical Ingredients Sales by Country (2019-2030)
3.5.3 Europe Animal Health Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Health Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Animal Health Active Pharmaceutical Ingredients Sales by Country (2019-2030)
3.6.3 Asia Pacific Animal Health Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Animal Health Active Pharmaceutical Ingredients Sales by Country (2019-2030)
3.7.3 Latin America Animal Health Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Health Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Animal Health Active Pharmaceutical Ingredients Sales by Country (2019-2030)
3.8.3 Middle East and Africa Animal Health Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Type (2019-2030)
4.1.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Type (2019-2024)
4.1.2 Global Animal Health Active Pharmaceutical Ingredients Sales by Type (2025-2030)
4.1.3 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Type (2019-2030)
4.2.1 Global Animal Health Active Pharmaceutical Ingredients Revenue by Type (2019-2024)
4.2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Type (2025-2030)
4.2.3 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Animal Health Active Pharmaceutical Ingredients Price by Type (2019-2030)
5 Segment by Application
5.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Application (2019-2030)
5.1.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Application (2019-2024)
5.1.2 Global Animal Health Active Pharmaceutical Ingredients Sales by Application (2025-2030)
5.1.3 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Application (2019-2030)
5.2.1 Global Animal Health Active Pharmaceutical Ingredients Revenue by Application (2019-2024)
5.2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Application (2025-2030)
5.2.3 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Animal Health Active Pharmaceutical Ingredients Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Glenmark Pharmaceutical
6.1.1 Glenmark Pharmaceutical Corporation Information
6.1.2 Glenmark Pharmaceutical Description and Business Overview
6.1.3 Glenmark Pharmaceutical Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Glenmark Pharmaceutical Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.1.5 Glenmark Pharmaceutical Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Sanofi Winthrop Industrie
6.4.1 Sanofi Winthrop Industrie Corporation Information
6.4.2 Sanofi Winthrop Industrie Description and Business Overview
6.4.3 Sanofi Winthrop Industrie Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Winthrop Industrie Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.4.5 Sanofi Winthrop Industrie Recent Developments/Updates
6.5 Indukern
6.5.1 Indukern Corporation Information
6.5.2 Indukern Description and Business Overview
6.5.3 Indukern Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Indukern Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.5.5 Indukern Recent Developments/Updates
6.6 P&R SpA (Olon SpA)
6.6.1 P&R SpA (Olon SpA) Corporation Information
6.6.2 P&R SpA (Olon SpA) Description and Business Overview
6.6.3 P&R SpA (Olon SpA) Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.6.4 P&R SpA (Olon SpA) Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.6.5 P&R SpA (Olon SpA) Recent Developments/Updates
6.7 Lonza Group
6.6.1 Lonza Group Corporation Information
6.6.2 Lonza Group Description and Business Overview
6.6.3 Lonza Group Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lonza Group Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.7.5 Lonza Group Recent Developments/Updates
6.8 Huvepharma
6.8.1 Huvepharma Corporation Information
6.8.2 Huvepharma Description and Business Overview
6.8.3 Huvepharma Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huvepharma Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.8.5 Huvepharma Recent Developments/Updates
6.9 Sequent Scientific
6.9.1 Sequent Scientific Corporation Information
6.9.2 Sequent Scientific Description and Business Overview
6.9.3 Sequent Scientific Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sequent Scientific Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.9.5 Sequent Scientific Recent Developments/Updates
6.10 NGL Fine Chem
6.10.1 NGL Fine Chem Corporation Information
6.10.2 NGL Fine Chem Description and Business Overview
6.10.3 NGL Fine Chem Animal Health Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2019-2024)
6.10.4 NGL Fine Chem Animal Health Active Pharmaceutical Ingredients Product Portfolio
6.10.5 NGL Fine Chem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Health Active Pharmaceutical Ingredients Industry Chain Analysis
7.2 Animal Health Active Pharmaceutical Ingredients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Health Active Pharmaceutical Ingredients Production Mode & Process
7.4 Animal Health Active Pharmaceutical Ingredients Sales and 麻豆原创ing
7.4.1 Animal Health Active Pharmaceutical Ingredients Sales Channels
7.4.2 Animal Health Active Pharmaceutical Ingredients Distributors
7.5 Animal Health Active Pharmaceutical Ingredients Customers
8 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Dynamics
8.1 Animal Health Active Pharmaceutical Ingredients Industry Trends
8.2 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Drivers
8.3 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Challenges
8.4 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Glenmark Pharmaceutical
Zoetis
Eli Lilly
Sanofi Winthrop Industrie
Indukern
P&R SpA (Olon SpA)
Lonza Group
Huvepharma
Sequent Scientific
NGL Fine Chem
听
听
*If Applicable.